Picture of Theraclion SA logo

ALTHE Theraclion SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapMomentum Trap

Brief: Theraclion FY Sales Up 44%

Jan 27 (Reuters) - Theraclion SA  ALTHER.PA :
    * 2019 : THERACLION DEMONSTRATES ITS LEADERSHIP IN THYROID
AND
VEINS NONE INVASIVE TREATMENTS
    * ACHIEVED A TURNOVER OF EUR 2,784 THOUSAND IN 2019
    * IN 2020, THERACLION EXPECTS TO REACH BETWEEN 30% AND 50%
SALES
GROWTH.
    * AT DECEMBER 31, 2019, THERACLION'S AVAILABLE CASH POSITION
AMOUNTED TO EUR 1.4 MILLION
    * THERACLION ESTIMATES THAT IT WILL BE ABLE TO COVER ITS
CASH
REQUIREMENTS UNTIL END OF 2020.

Source text for Eikon:  ID:nBw92QRbga 
Further company coverage:  ALTHER.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))

Recent news on Theraclion SA

See all news